Sarah A. Teichmann sold $147k of TXG
director at 10x Genomics, Inc.. 7,579 shares at an average of $19.41, traded Feb 25, 2026, filed Feb 27, 2026.
Score components
- +15RoleDirector
- +11Trade size$147k at market
- +5Share of holdings soldSold 22% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.5%, 3m +22.8%, 6m +167.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-26-000074, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -7,579 | $19.41 | $147k | 26,780 | Feb 27, 2026 |
Related signals
Other insiders at 10x Genomics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $2.0M 25,000 shares | -2% | |
| 32Weak | 10x Genomics, Inc. | Shehnaaz Suliman director | $465k 5,723 shares | -19% | |
| 47Moderate | 10x Genomics, Inc. | Adam Taich Chief Financial Officer | $3.0M 46,388 shares | -13% | |
| 55Moderate | 10x Genomics, Inc. | John R Stuelpnagel director | $1.2M 20,000 shares | -6% | |
| 40Moderate | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $668k 10,486 shares | -1% | |
| 21Weak | 10x Genomics, Inc. | Shehnaaz Suliman director | $140k 2,207 shares | -7% | |
| 53Moderate | 10x Genomics, Inc. | Benjamin J. Hindson See Remarks | $871k 13,818 shares | -3% | |
| 62Notable | 10x Genomics, Inc. | Adam Taich Chief Financial Officer | $1.1M 17,166 shares | -5% | |
| 65Notable | 10x Genomics, Inc. | Serge Saxonov Chief Executive Officer | $1.2M 18,545 shares | -2% | |
| 32Weak | 10x Genomics, Inc. | Sarah A. Teichmann director | $432k 7,551 shares | -21% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.